Sign In
Buy ACNT
Ascent Industries Earnings Calls
| Release date | Nov 04, 2025 |
| EPS estimate | $0.290 |
| EPS actual | $0.0100 |
| EPS Surprise | -96.55% |
| Revenue estimate | 59.4M |
| Revenue actual | 19.697M |
| Revenue Surprise | -66.84% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.270 |
| EPS actual | -$0.0800 |
| EPS Surprise | -129.63% |
| Revenue estimate | 56.9M |
| Revenue actual | 18.652M |
| Revenue Surprise | -67.22% |
| Release date | May 12, 2025 |
| EPS estimate | $0.120 |
| EPS actual | -$0.0800 |
| EPS Surprise | -166.67% |
| Revenue estimate | 48.9M |
| Revenue actual | 24.732M |
| Revenue Surprise | -49.42% |
| Release date | Mar 04, 2025 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0100 |
| EPS Surprise | -66.67% |
| Revenue estimate | 46.4M |
| Revenue actual | 40.671M |
| Revenue Surprise | -12.35% |
Last 4 Quarters for Ascent Industries
Below you can see how ACNT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 04, 2025 |
| Price on release | $11.05 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0100 |
| EPS surprise | -66.67% |
| Date | Price |
|---|---|
| Feb 26, 2025 | $11.12 |
| Feb 27, 2025 | $11.19 |
| Feb 28, 2025 | $11.18 |
| Mar 03, 2025 | $11.07 |
| Mar 04, 2025 | $11.05 |
| Mar 05, 2025 | $11.58 |
| Mar 06, 2025 | $11.84 |
| Mar 07, 2025 | $11.61 |
| Mar 10, 2025 | $11.70 |
| 4 days before | -0.629% |
| 4 days after | 5.88% |
| On release day | 4.80% |
| Change in period | 5.22% |
| Release date | May 12, 2025 |
| Price on release | $12.82 |
| EPS estimate | $0.120 |
| EPS actual | -$0.0800 |
| EPS surprise | -166.67% |
| Date | Price |
|---|---|
| May 06, 2025 | $13.22 |
| May 07, 2025 | $13.01 |
| May 08, 2025 | $12.80 |
| May 09, 2025 | $12.86 |
| May 12, 2025 | $12.82 |
| May 13, 2025 | $11.90 |
| May 14, 2025 | $11.65 |
| May 15, 2025 | $11.98 |
| May 16, 2025 | $12.39 |
| 4 days before | -3.03% |
| 4 days after | -3.35% |
| On release day | -7.18% |
| Change in period | -6.28% |
| Release date | Aug 06, 2025 |
| Price on release | $13.07 |
| EPS estimate | $0.270 |
| EPS actual | -$0.0800 |
| EPS surprise | -129.63% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $12.83 |
| Aug 01, 2025 | $12.66 |
| Aug 04, 2025 | $12.92 |
| Aug 05, 2025 | $13.01 |
| Aug 06, 2025 | $13.07 |
| Aug 07, 2025 | $12.96 |
| Aug 08, 2025 | $13.11 |
| Aug 11, 2025 | $12.94 |
| Aug 12, 2025 | $12.86 |
| 4 days before | 1.87% |
| 4 days after | -1.61% |
| On release day | -0.84% |
| Change in period | 0.234% |
| Release date | Nov 04, 2025 |
| Price on release | $11.97 |
| EPS estimate | $0.290 |
| EPS actual | $0.0100 |
| EPS surprise | -96.55% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $12.20 |
| Oct 30, 2025 | $12.14 |
| Oct 31, 2025 | $12.16 |
| Nov 03, 2025 | $12.08 |
| Nov 04, 2025 | $11.97 |
| Nov 05, 2025 | $12.54 |
| Nov 06, 2025 | $12.42 |
| Nov 07, 2025 | $12.69 |
| Nov 10, 2025 | $12.69 |
| 4 days before | -1.89% |
| 4 days after | 6.02% |
| On release day | 4.76% |
| Change in period | 4.02% |
Ascent Industries Earnings Call Transcript Summary of Q3 2025
Ascent Industries reported a strong Q3 2025 as a pure-play specialty chemical company, with revenue of $19.7M (up ~6% sequentially, down 6% YoY), gross profit of $5.8M and gross margin expansion to ~29.7% (up ~400 bps QoQ). Adjusted EBITDA improved to $1.4M (7% margin) driven by portfolio repositioning, pricing discipline and cost actions. Management emphasized structural — not episodic — margin gains, successful ERP implementation, and growing commercial momentum: 49% of a $25M Q2 pipeline converted to commitments (~$12.5M) and $18.2M of new selling projects added in Q3. Key end markets driving wins include coatings/adhesives/sealants/elastomers, water treatment and infrastructure. Balance sheet strength: $58M cash, no debt and $13.7M revolver availability; management remains patient on M&A and prioritizes organic growth, internal capacity utilization (currently ~50%), disciplined capital allocation and potential share buybacks. Near-term risks/management focus: employee retention through the transformation and executing operations to scale with commercial wins. Management expects sustainable gross margins at/above 30% with modest further upside and believes adjusted EBITDA in the high single digits to low-teens (management cited ~10% as a target) will support sustained positive operating cash flow.
